Atopic Dermatitis Control Tool (ADCT): A useful tool for self‐evaluation in patients with atopic dermatitis

2021 ◽  
Author(s):  
Makiko Kido‐Nakahara ◽  
Ginju Yokote ◽  
Maiko Yoshida ◽  
Masutaka Furue ◽  
Takeshi Nakahara
Keyword(s):  
Atopic Dermatitis ◽  
Self Evaluation ◽  
Control Tool

scholarly journals Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis

2019 ◽  
Author(s):  
Eric Simpson ◽  
Laurent Eckert ◽  
Abhijit Gadkari ◽  
Usha G. Mallya ◽  
Min Yang ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Life Quality ◽  
Well Being ◽  
Patient Survey ◽  
Survey Study ◽  
Baseline Survey ◽  
Group Validity ◽  
Test Retest Reliability ◽  
Prospective Longitudinal ◽  
Control Tool

Abstract Background: The Atopic Dermatitis Control Tool (ADCT©) is a brief patient self-administered instrument designed and validated to assess atopic dermatitis (AD) control; six AD symptoms and impacts are evaluated over the past week, including overall severity of symptoms, days with intense episodes of itching, intensity of bother, problem with sleep, impact on daily activities, and impact on mood or emotions. This study assessed the reliability, validity, and responsiveness of the ADCT in a longitudinal context, and provided thresholds to identify meaningful within-person change. Methods: Data were from a prospective, longitudinal patient survey study of real-world effectiveness of dupilumab in patients with AD. Eligible patients completed a baseline survey before starting dupilumab and were followed at Months 1, 2, 3, and 6 post-initiation as they became eligible. Results: Psychometric analyses confirmed internal consistency; Cronbach’s α coefficients were consistently above the threshold of 0.70 across each follow-up, while item-to-total correlations were above the threshold of r ≥ 0.50. High correlations between the ADCT and the Dermatology Life Quality Index (DLQI) and skin pain supported construct validity, while known-group validity was shown on Patient Global Assessment of Disease (PGAD) overall well-being subgroups with worse AD-related overall well-being having higher mean ADCT total scores at all time points. The ability of the ADCT to detect change was confirmed; the threshold for meaningful within-person change was estimated to be 5 points. Finally, test–retest reliability was confirmed in subgroups of patients with stable PGAD responses. Conclusions: Our findings confirm that the ADCT is a valid and reliable tool for assessing AD control.

scholarly journals Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis

2019 ◽  
Author(s):  
Eric Simpson ◽  
Laurent Eckert ◽  
Abhijit Gadkari ◽  
Usha G. Mallya ◽  
Min Yang ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Life Quality ◽  
Well Being ◽  
Patient Survey ◽  
Survey Study ◽  
Baseline Survey ◽  
Group Validity ◽  
Test Retest Reliability ◽  
Prospective Longitudinal ◽  
Control Tool

Abstract Background: The Atopic Dermatitis Control Tool (ADCT©) is a brief patient self-administered instrument designed and validated to assess atopic dermatitis (AD) control; six AD symptoms and impacts are evaluated over the past week, including overall severity of symptoms, days with intense episodes of itching, intensity of bother, problem with sleep, impact on daily activities, and impact on mood or emotions. This study assessed the reliability, validity, and responsiveness of the ADCT in a longitudinal context, and provided thresholds to identify meaningful within-person change. Methods: Data were from a prospective, longitudinal patient survey study of real-world effectiveness of dupilumab in patients with AD. Eligible patients completed a baseline survey before starting dupilumab and were followed at Months 1, 2, 3, and 6 post-initiation as they became eligible. Results: Psychometric analyses confirmed internal consistency; Cronbach’s α coefficients were consistently above the threshold of 0.70 across each follow-up, while item-to-total correlations were above the threshold of r ≥ 0.50. High correlations between the ADCT and the Dermatology Life Quality Index (DLQI) and skin pain supported construct validity, while known-group validity was shown on Patient Global Assessment of Disease (PGAD) overall well-being subgroups with worse AD-related overall well-being having higher mean ADCT total scores at all time points. The ability of the ADCT to detect change was confirmed; the threshold for meaningful within-person change was estimated to be 5 points. Finally, test–retest reliability was confirmed in subgroups of patients with stable PGAD responses. Conclusions: Our findings confirm that the ADCT is a valid and reliable tool for assessing AD control.

scholarly journals Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis

2019 ◽  
Author(s):  
Laurent Eckert ◽  
Abhijit Gadkari ◽  
Usha G. Mallya ◽  
Min Yang ◽  
Lauren Nelson ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Life Quality ◽  
Well Being ◽  
Patient Survey ◽  
Survey Study ◽  
Baseline Survey ◽  
Group Validity ◽  
Test Retest Reliability ◽  
Prospective Longitudinal ◽  
Control Tool

Abstract Background: The Atopic Dermatitis Control Tool (ADCT©) is a brief patient self-administered instrument designed and validated to assess atopic dermatitis (AD) control; six AD symptoms and impacts are evaluated over the past week, including overall severity of symptoms, days with intense episodes of itching, intensity of bother, problem with sleep, impact on daily activities, and impact on mood or emotions. This study assessed the reliability, validity, and responsiveness of the ADCT in a longitudinal context, and provided thresholds to identify meaningful within-person change. Methods: Data were from a prospective, longitudinal patient survey study of real-world effectiveness of dupilumab in patients with AD. Eligible patients completed a baseline survey before starting dupilumab and were followed at Months 1, 2, 3, 6, 9, and 12 post-initiation as they became eligible. Results: Psychometric analyses confirmed internal consistency; Cronbach’s α coefficients were consistently above the threshold of 0.70 across each follow-up, while item-to-total correlations were above the threshold of r ≥ 0.50. High correlations between the ADCT and the Dermatology Life Quality Index (DLQI) and skin pain supported construct validity, while known-group validity was shown on Patient Global Assessment of Disease (PGAD) overall well-being subgroups with worse AD-related overall well-being having higher mean ADCT total scores at all time points. The ability of the ADCT to detect change was confirmed; the threshold for meaningful within-person change was estimated to be 5 points. Finally, test–retest reliability was confirmed in subgroups of patients with stable PGAD responses. Conclusions: Our findings confirm that the ADCT is a valid and reliable tool for assessing AD control.

scholarly journals Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT)

2019 ◽  
Vol 36 (3) ◽  
pp. 367-376 ◽  
Author(s):  
David M. Pariser ◽  
Eric L. Simpson ◽  
Abhijit Gadkari ◽  
Thomas Bieber ◽  
David J. Margolis ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Perceived Control ◽  
Design Validation ◽  
Control Tool

scholarly journals Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Eric Simpson ◽  
Laurent Eckert ◽  
Abhijit Gadkari ◽  
Usha G. Mallya ◽  
Min Yang ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Life Quality ◽  
Well Being ◽  
Patient Survey ◽  
Survey Study ◽  
Baseline Survey ◽  
Group Validity ◽  
Test Retest Reliability ◽  
Prospective Longitudinal ◽  
Control Tool

Abstract Background The Atopic Dermatitis Control Tool (ADCT©) is a brief patient self-administered instrument designed and validated to assess atopic dermatitis (AD) control; six AD symptoms and impacts are evaluated over the past week, including overall severity of symptoms, days with intense episodes of itching, intensity of bother, problem with sleep, impact on daily activities, and impact on mood or emotions. This study assessed the reliability, validity, and responsiveness of the ADCT in a longitudinal context, and provided thresholds to identify meaningful within-person change. Methods Data were from a prospective, longitudinal patient survey study of real-world effectiveness of dupilumab in patients with AD. Eligible patients completed a baseline survey before starting dupilumab and were followed at Months 1, 2, 3, and 6 post-initiation as they became eligible. Results Psychometric analyses confirmed internal consistency; Cronbach’s α coefficients were consistently above the threshold of 0.70 across each follow-up; item-to-total correlations were above the threshold of r ≥ 0.50. High correlations between the ADCT and the Dermatology Life Quality Index (DLQI) and skin pain supported construct validity, while known-group validity was shown on Patient Global Assessment of Disease (PGAD) overall well-being subgroups with worse AD-related overall well-being having higher mean ADCT total scores at all time points. The ability of the ADCT to detect change was confirmed; the threshold for meaningful within-person change was estimated to be 5 points. Finally, test–retest reliability was confirmed in subgroups of patients with stable PGAD responses. Conclusions Our findings confirm that the ADCT is a valid and reliable tool for assessing AD control.

scholarly journals Evaluation of long‐term disease control with dupilumab therapy using the Atopic Dermatitis Control Tool in real‐world clinical practice

2021 ◽  
Author(s):  
Marin Kunimoto ◽  
Yasutomo Imai ◽  
Masako Matsutani ◽  
Minori Nakatani‐Kusakabe ◽  
Makoto Nagai ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Clinical Practice ◽  
Disease Control ◽  
Real World ◽  
Control Tool

scholarly journals The Atopic Dermatitis Control Tool, A High-Performance Tool for Optimal Support

2021 ◽  
Author(s):  
Delphine Staumont ◽  
Charles Taieb ◽  
Stephanie Merhand ◽  
Jason Shourick
Keyword(s):  
Atopic Dermatitis ◽  
High Performance ◽  
Disease Burden ◽  
Personal Information ◽  
High Stress ◽  
Real Life ◽  
Multiple Dimensions ◽  
Key Factor ◽  
High Stress Level ◽  
Control Tool

The evaluation of global atopic dermatitis control is key to minimizing the disease burden. The Atopic Dermatitis Control Tool (ADCT) has been developed for this purpose. Participants [diagnosed by a physician] were recruited using a real-life methodology and asked to answer a questionnaire to provide sociodemographic and personal information. The ADCT algorithm described by Pariser was used to categorize patients as having controlled or uncontrolled atopic dermatitis. Data were collected on 1606 patients. The patients’ median age was 40 quartiles [31, 42.45] years, and 1,023 (63.7%) patients were women. A total of 1,146 (71.4%) patients did not have controlled atopic dermatitis according to the ADCT score. Patients with uncontrolled disease were at a significantly higher risk of a high stress level and had more opportunities to miss work than patients with controlled disease. In this study, we showed that a key factor for predicting the disease burden is patient self-assessed disease control in terms of multiple dimensions: stress, sleep, quality of life, work absenteeism and loss of productivity.

scholarly journals Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis

2019 ◽  
Author(s):  
Eric Simpson ◽  
Laurent Eckert ◽  
Abhijit Gadkari ◽  
Usha G. Mallya ◽  
Min Yang ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Life Quality ◽  
Well Being ◽  
Patient Survey ◽  
Survey Study ◽  
Baseline Survey ◽  
Group Validity ◽  
Test Retest Reliability ◽  
Prospective Longitudinal ◽  
Control Tool

Abstract Background: The Atopic Dermatitis Control Tool (ADCT©) is a brief patient self-administered instrument designed and validated to assess atopic dermatitis (AD) control; six AD symptoms and impacts are evaluated over the past week, including overall severity of symptoms, days with intense episodes of itching, intensity of bother, problem with sleep, impact on daily activities, and impact on mood or emotions. This study assessed the reliability, validity, and responsiveness of the ADCT in a longitudinal context, and provided thresholds to identify meaningful within-person change. Methods: Data were from a prospective, longitudinal patient survey study of real-world effectiveness of dupilumab in patients with AD. Eligible patients completed a baseline survey before starting dupilumab and were followed at Months 1, 2, 3, and 6 post-initiation as they became eligible. Results: Psychometric analyses confirmed internal consistency; Cronbach’s α coefficients were consistently above the threshold of 0.70 across each follow-up, while item-to-total correlations were above the threshold of r ≥ 0.50. High correlations between the ADCT and the Dermatology Life Quality Index (DLQI) and skin pain supported construct validity, while known-group validity was shown on Patient Global Assessment of Disease (PGAD) overall well-being subgroups with worse AD-related overall well-being having higher mean ADCT total scores at all time points. The ability of the ADCT to detect change was confirmed; the threshold for meaningful within-person change was estimated to be 5 points. Finally, test–retest reliability was confirmed in subgroups of patients with stable PGAD responses. Conclusions: Our findings confirm that the ADCT is a valid and reliable tool for assessing AD control.

Student self-evaluation in preclinical restorative dentistry

1982 ◽  
Vol 46 (4) ◽  
pp. 221-226 ◽  
Author(s):  
LS Forehand ◽  
WF Vann ◽  
DA Shugars
Keyword(s):  
Restorative Dentistry ◽  
Self Evaluation

Student Clinicians Self-Evaluating Performance by Reviewing Session Videos and Using a Rubric

2015 ◽  
Vol 25 (2) ◽  
pp. 78-84 ◽  
Author(s):  
Holly C. Smith
Keyword(s):  
Clinical Education ◽  
Crucial Element ◽  
Self Evaluation ◽  
Pertinent Information ◽  
Evaluation Rubrics

Development of self-evaluation skills in student clinicians is a crucial element of clinical education. This article reviews pertinent information regarding supervisors' responsibilities related to teaching supervisees to self-evaluate. Previously identified methods of facilitating these skills are discussed. The use of video self-analyses paired with self-evaluation rubrics is explored.

Sign in / Sign up

Export Citation Format

Share Document